中国鼻咽癌分期2017版(2008鼻咽癌分期修订专家共识)
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
中国鼻咽癌分期2017版(2008鼻咽癌分期修订专家共识)
中国鼻咽癌分期2017版(2008鼻咽癌分期修订专家共识)中国鼻咽癌临床分期工作委员会
【期刊名称】《中华放射肿瘤学杂志》
【年(卷),期】2017(026)010
【摘要】The staging of malignant tumors is a fundamental component of treatment selection, prognosis prediction and academic exchange. As"Chinese 2008 staging for nasopharyngeal carcinoma ( NPC)"was widely adopted in China from 2009, more and more coordination and exchange of information has been carried out between treatment centers, which has promoted the development of multicenter clinical trials and staging studies. On July 1, 2017, an expert consensus conference was held by the Chinese Committee for Staging of NPC to discuss the revision of Chinese 2008 staging for NPC in Nanping City, Fujian Province. After a full discussion and communication according to evidence-based medicine, a consensus was made. The 8th edition UICC/AJCC staging system for NPC was more rational because it had incorporated the strengths of the Chinese 2008 and the 7th edition UICC/AJCC staging systems. Chinese 2008 staging should be revised based on the 8th edition UICC/AJCC staging system to make an internationally unified staging system. Therefore, the experts strongly recommended Chinese 2017 staging for NPC should be consistent with the 8th edition UICC/AJCC staging system.%准确的肿瘤临床分期是指导治